NVDA selloff: panic or discount?

Asian markets slid hard in mid-October: Korea's index fell to its 200-day line while Samsung and SK Hynix led memory names lower. CNBC framed it on October 13 as an extension of US tech weakness. Watching the FinVid compilation on YouTube, my take was simple: fear moved faster than figures. So I separated price from revenue before doing anything. Price can panic; contracted revenue rarely does.

Dan Ives, speaking from Seoul, called the selloff overdone: nerves around Chinese rivals plus fear of a datacenter pause. I lean his way because demand still outruns supply by miles, with orders reportedly running near thirteen to one. What investors await is earnings season. Strong prints usually end fear waves with a fast rebound. So I stay selective by name instead of selling the whole index.

One amplifier was Broadcom chief Hock Tan's Singapore remarks, headlined as investors gambling. The BusinessTimes record shows a narrower point about buyers acting on extreme hopes without homework. His criticism targeted short-term sellers after the OpenAI revenue story, not holders. One misread sentence poisoned a whole valuation debate. Read the speech, not the headline.

The bear case also clashes with figures: Broadcom just extended a $42B loan to Anthropic. Nobody backs a casino with that size of commitment. OpenAI itself is racing toward $50B in annualized revenue while still loss-making from training spend. My read: growth is real, profit is a scale question. Short-term sellers miss that split; long-term holders can treat it as noise.

The second pressure source came from China: CXMT claimed key progress on a new memory design and SCMP put it on the front page on October 12. Speed-readers concluded China had caught Samsung and SK Hynix, yet the notice had no volume, yield, or customer. I treat one-line breakthroughs with care: they are no reason to sell equity. Shorts piling onto the headline looked opportunistic, not analytic.

What is concrete in China is YMTC: CounterpointResearch data puts it third worldwide in shipments last quarter at fourteen percent, behind Samsung at twenty-five and SK Hynix at twenty-two. Its Shanghai STAR listing is progressing with a $4.9B target. My lesson: China is no longer marginal in memory, yet third place sits far from the lead. For holders, that gap can mean discounts in Korean names until prints close it.

Micron's figures look strong: Micron closed its fiscal year with record results and guides about $61.5B in revenue next quarter. The multiple sits in single digits, a buyback runs alongside, and take-or-pay pacts lock in price stability. To me the equity lags profit growth by a wide margin. Bears call these parts commodity and cite past cycles, yet today's pull comes from contracted AI demand. I read this print as a discount, not a warning.

Optics carry a similar fog: summer rumors said China would flood the market, but no official ban followed. The reality is calmer: the brains (signal processors) sit with Marvell and Broadcom on domestic lines, while lasers and packaging stay tight. Supply from Coherent and Lumentum is rising and designs shift toward co-packaged optics within two to three years. For me that is a duration question: I will not drop a decade-long story over two foggy years.

BlueBird's Annie Sin handles the circular-funding worry honestly: hyperscaler buildout runs near $1T for 2027 with a backlog near $2T, yet most of it rests on two or three loss-making names. As free versions improve, those revenues face debate, and the books stay closed. I respect that risk: markets punish circular promises first. So I build positions in steps ; full order books still deserve payment checks.

The big picture still shows open taps: SPGlobal sees infrastructure outlay above $1.3T by 2027 and CNBC carries a similar $1T band. Rates run high and free cash stays negative into 2029, but cloud income plus stacked orders carry the frame. My lesson as a small holder: buying while rates bite takes nerve, yet waiting is also a choice. So I add in slices and never chase a rebound before rates turn.

My winners list is short: Microsoft in cloud, NVDA in accelerators, Palantir and CrowdStrike in software. Microsoft owns enterprise rollout while NVDA holds a roadmap into 2028. Meta opening Muse to 3.6B users only speeds the race. I build my portfolio the same way: equity as the pillar, cash as the beam. No single name carries the roof, and I never abandon the plan when a rebound escapes me.

NVDA is shifting up in Europe: the Nvidia team toured the continent before GTC Berlin (October 20-22, keynote October 21 at the Tempodrom), with startup bets in France and about $2B in fresh pledges discussed. On software, opening Run:ai code to all sets a standard across the DSX ecosystem. To me that spells roots on the continent: headlines near term, income long term. As European income grows, the valuation debate softens.

The product cadence is clear too: the TechCrunch rundown has Blackwell Ultra in the field, Vera Rubin in late 2026, Rubin Ultra in 2027, Feynman in 2028. Each step multiplies speed and efficiency. Jensen's $3-4T yearly factory vision sounds bold, but if shortage lasts into 2028, time sides with holders. My plan stays calm : buy in steps, skip the chase, confirm with prints.